Five Decades of Partnership in Solid Oral Dose Manufacturing
Q&A Pharma Matters with Yves Massicotte - Contract Pharma 2026
How Ropack’s evolution from service provider to strategic CMO partner reflects broader shifts in manufacturing, packaging, and quality expectations.
As pharmaceutical outsourcing has matured, contract manufacturing organizations (CMOs) have evolved from capacity-driven service providers into strategic partners deeply embedded in their customers’ development and commercialization strategies. Nowhere is this shift more evident than in solid oral dose manufacturing and packaging, where increasing formulation complexity, compressed timelines, and heightened regulatory expectations demand both technical depth and operational agility.
In 2026, Ropack Pharma Solutions marks its 50th anniversary— a milestone that reflects not only longevity, but sustained relevance in a highly competitive CMO market. In this Contract Pharma Q&A, Yves Massicotte, President and CEO of Ropack, shares his perspective on how the role of CMOs has changed over the past five decades, how Ropack has expanded its manufacturing and packaging capabilities to meet modern demands, and what qualities pharma and nutraceutical companies should prioritize when selecting a long-term outsourcing partner.
